Product Program year 2024 Source: CMS Open Payments

Edora 8 DR-T

Device Cardiology/Vascular Diseases

PDI 04035479147648

Open in the dashboard

General payments

$1,372,579

4,984 payments

Research payments

$69,152

13 payments

Through program year 2024, $1,372,579 in general payments and $69,152 in research payments were reported against Edora 8 DR-T (Cardiology/Vascular Diseases).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2024 General $211,994 71
2023 General $236,439 838
2022 General $924,146 4,075
2022 Research $69,152 13

Breakdown

Who paid General payments · program years 2022–2024
  1. Biotronik Inc. $1,372,579 4,984 payments
Top recipients General payments · program year 2024
  1. Community Regional Medical Center Teaching hospital · CA $15,843 7% · 1 payment
  2. Scripps Green Hospital Teaching hospital · CA $13,809 7% · 7 payments
  3. South Shore University Hospital Teaching hospital · NY $12,047 6% · 2 payments
  4. Spring Valley Hospital Medical Cntr Teaching hospital · NV $9,304 4% · 2 payments
  5. Henderson Hospital Teaching hospital · NV $9,304 4% · 2 payments

The top 5 of 53 recipients; each share is of general payments naming this product in 2024.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2024
  1. Clinical Cardiac Electrophysiology Internal Medicine $4,000 66% · 4 practitioners
  2. Advanced Heart Failure and Transplant Cardiology Internal Medicine $1,046 17% · 2 practitioners
  3. Nurse Practitioner $599 10% · 1 practitioner
  4. Cardiovascular Disease Internal Medicine $450 7% · 1 practitioner

Each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2024
  1. California $58,916 28% · 9 recipients
  2. New York $29,149 14% · 5 recipients
  3. Florida $23,997 11% · 7 recipients
  4. Nevada $18,609 9% · 2 recipients
  5. Texas $10,332 5% · 3 recipients

The top 5 of 20 states; each share is of general payments naming this product in 2024 where a state was reported.

The top 25 states, free in the app

4,984 general · 13 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2024

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record